Very Old Episodes
6.7 Dr Esther Clift DClinP - Joining the Dots; Frailty & Physiotherapy
We chat to Physiotherapist and Consultant Practitioner, Esther Clift about her pioneering role in the management of frailty & how the Isle of Wight, as a ‘petri-dish’ of frailty, is the ideal place for this role.
6.4 Professor Tony Avery OBE - The Problem with Prescribing?
How do you influence the prescribing habits of an entire country? This is the task of NHS England’s National Clinical Director of Prescribing Professor Tony Avery.
4.4 - Dr Nkiruka Umaru. Tea, cake and medicines.
A real pleasure this week to welcome one the Pharmaceutical Journal's ‘Women to Watch in 2022’ Nkiruku Umuaru. Nikkie is currently the Pharmacy Foundation Head of School, Interim Education and Postgraduate Pharmacy Lead at the University of Herefordshire. We chat to Nikkie about medicines in older people, and in particular how to have good conversations with them about their medicines.
4.1 - Getting Older and how to deal with it - with bestselling author Dr Lucy Pollock
We are joined by Consultant Geriatrician and bestselling author Dr Lucy Pollock. As Lucy tells us - we all become old if we are lucky. But how do we deal with it - as people and as health professionals? We chat about Lucy’s experience in working with the elderly and the importance of honesty, humour and shared decision making.
Episode 2.10 - Dr Mark Holland - The Needy not the Noisy
Dr Mark Holland is Associate Professor at the University of Bolton & formerly a Consultant in geriatric medicine at Wythenshawe Hospital, Manchester, before moving into Acute Medicine. Formerly President of the Society for Acute Medicine he did so many TV interviews on behalf of his profession he ended up with his own IMDB database!
Episode 2.8 - Lelly Oboh - Wicked Problems, Mindlines and the Stripey Zebra.
Lelly began her career in community pharmacy and then worked as a primary care pharmacist, becoming the first UK community based consultant pharmacist in 2007. Her current role is at Guys and St Thomas and involves optimising medicines use in frailty, multimorbidity and polypharmacy.